Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy

Research To Practice | Oncology Videos

Featuring an interview with Dr Andrew H Wei on the following topics:

• Treatment of acute myeloid leukemia (AML) in patients not eligible for intensive induction therapy (0:00)
• Case: A man in his late 70s with AML receives re-treatment with venetoclax and azacitidine after attaining a durable remission of 2.5 years with that regimen (21:23)
• Case: A woman in her late 70s initially diagnosed with AML with an IDH2 mutation receives gilteritinib as third-line therapy after detection of a FLT3-ITD mutation (23:16)

CME information and select publications